An Exploration of Ranibizumab Injection Frequency in Patients with Diabetic Macular Edema: A Post-hoc Analysis of the Restore and Retain Study

被引：0
|
作者：
Figueira, Joao [1 ]
Margaron, Philippe [2 ]
Hashmonay, Ron [2 ]
机构：
[1] AIBILI, Coimbra, Portugal
[2] Novartis Pharma AG, Basel, Switzerland
来源：
OPHTHALMOLOGICA | 2014年 / 232卷
关键词：
Diabetic Macular Edema; Ranibizumab; RESTORE Study; RETAIN Study; Visual Acuity;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
160
引用
收藏
页码：19 / 19
页数：1
相关论文
共 50 条
  • [1] Achievement of ≥20/40 vision with ranibizumab in patients with diabetic macular edema: a post-hoc analysis of the RESTORE study
    Chong, Victor
    Alsop, Jonathan
    Margaron, Philippe
    Mitchell, Paul
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [2] High visual acuity response with reduced number of ranibizumab injections in patients with diabetic macular edema: a post-hoc analysis of the RESTORE study
    Margaron, Philippe
    Bailey, Clare
    Spital, Georg
    Warburton, James
    Hashmonay, Ronny
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [3] Ranibizumab 0.5 mg injections required within the first year of a flexible treatment regimen in diabetic macular edema patients: a post-hoc analysis of RESTORE and RETAIN
    Framme, Carsten
    Margaron, Philippe
    Hashmonay, Ron
    Eter, Nicole
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [4] TREATMENT PATTERNS AND INJECTION FREQUENCY OF RANIBIZUMAB 0.5 MG WITHIN THE FIRST YEAR OF AN INDIVIDUALISED DOSING REGIMEN IN PATIENTS WITH DIABETIC MACULAR OEDEMA (DME): A POST-HOC ANALYSIS OF THE RESTORE AND RETAIN STUDIES
    Mitchell, Paul
    Framme, Carsten
    Eter, Nicole
    Margaron, Philippe
    Hastunonay, Ronny
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2015, 43 : 121 - 121
  • [5] PREDICTORS OF?6/12 VISION WITH RANIBIZUMAB 0.5MG TREATMENT IN PATIENTS WITH DIABETIC MACULAR OEDEMA (DME): A POST-HOC ANALYSIS OF THE RESTORE STUDY
    Mitchell, Paul
    Margaron, Philippe
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2016, 44 : 133 - 133
  • [6] HIGH VISUAL ACUITY RESPONSE WITH LOW NUMBER OF RANIBIZUMAB INJECTIONS IN PATIENTS WITH DIABETIC MACULAR OEDEMA: A POST HOC ANALYSIS OF THE RESTORE STUDY
    Mitchell, Paul
    Margaron, Philippe
    Bailey, Claire
    Spital, Georg
    Warburton, James
    Hashmonay, Ron
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2014, 42 : 118 - 118
  • [7] Correlation of functional and anatomical improvement following treatment for Diabetic Macular Edema: a post-hoc analysis
    Khowaja, Aly Hamza
    Janjua, Kholood
    Afridi, Rubbia
    Ahmed, Mohamed Ibrahim
    Halim, Muhammad Sohail
    Quan Dong Nguyen
    Sepah, Yasir Jamal
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [8] Association of Changes in Macular Perfusion With Ranibizumab Treatment for Diabetic Macular Edema A Subanalysis of the RESTORE (Extension) Study
    Karst, Sonja G.
    Deak, Gabor G.
    Gerendas, Bianca S.
    Waldstein, Sebastian M.
    Lammer, Jan
    Simader, Christian
    Guerin, Tadhg
    Schmidt-Erfurth, Ursula M.
    JAMA OPHTHALMOLOGY, 2018, 136 (04) : 315 - 321
  • [9] Influence of Glycosylated Hemoglobin on the Efficacy of Ranibizumab for Diabetic Macular Edema A Post Hoc Analysis of the RIDE/RISE Trials
    Bansal, Alok S.
    Khurana, Rahul N.
    Wieland, Mark R.
    Wang, Pin-Wen
    Van Everen, Sherri A.
    Tuomi, Lisa
    OPHTHALMOLOGY, 2015, 122 (08) : 1573 - 1579
  • [10] INTRAVITREAL INJECTION OF RANIBIZUMAB DURING CATARACT SURGERY IN PATIENTS WITH DIABETIC MACULAR EDEMA
    Rauen, Paulo I.
    Ribeiro, Jefferson A. S.
    Almeida, Felipe P. P.
    Scott, Ingrid U.
    Messias, Andre
    Jorge, Rodrigo
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2012, 32 (09): : 1799 - 1803
12345